Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden; Division of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
Bone. 2021 Jun;147:115909. doi: 10.1016/j.bone.2021.115909. Epub 2021 Mar 12.
Declining trends of hip fracture incidence in dialysis patients were reported from USA and Japan while studies from Europe are lacking. We investigated trends in hip fracture incidence and subsequent mortality in Swedish dialysis patients, comparing with the Swedish general population.
We used the population-based Swedish national database of fractures and the Swedish National Renal Registry to retrieve data on hip fractures incidence and subsequent mortality for years 2007-2016. Trends for age-standardized hip fracture incidence rate (ASR) and age-standardized 30-day (ASMR) and 180-day (ASMR) post-hip fracture mortality rate in Swedish general population were evaluated by joinpoint regression analysis. Standardized incidence ratios of hip fracture (SIR) and standardized mortality ratios (SMR) were calculated for Swedish dialysis patients.
In the general population, ASR declined significantly: in women from 2007 and in men from 2009. In dialysis patients, SIR was 3-5 times higher compared to the general population and declined over time in women but not in men. In general population, mortality (ASMR and ASMR) declined significantly in women and men. In dialysis patients, post-fracture mortality (SMR, mainly for 180-day mortality) remained two-fold higher than in general population with no consistent trend towards improvement.
Hip fracture incidence and subsequent mortality fell among women and men in the Swedish general population. In dialysis patients, hip fracture incidence declined in women but not in men while post-fracture mortality did not improve, and the incidence and subsequent mortality remained 3 to 5-fold and 2-fold higher than in the general population.
美国和日本的研究报告称,透析患者的髋部骨折发病率呈下降趋势,而欧洲的研究则缺乏此类报告。我们调查了瑞典透析患者髋部骨折发病率和随后死亡率的趋势,并与瑞典普通人群进行了比较。
我们使用基于人群的瑞典国家骨折数据库和瑞典国家肾脏登记处,检索了 2007 年至 2016 年髋部骨折发病率和随后死亡率的数据。通过 joinpoint 回归分析评估了瑞典普通人群中年龄标准化髋部骨折发生率(ASR)以及年龄标准化 30 天(ASMR)和 180 天(ASMR)髋部骨折后死亡率的趋势。计算了瑞典透析患者的髋部骨折标准化发病率比(SIR)和标准化死亡率比(SMR)。
在普通人群中,ASR 显著下降:女性从 2007 年开始下降,男性从 2009 年开始下降。在透析患者中,SIR 比普通人群高 3-5 倍,并且在女性中随时间下降,但在男性中没有下降。在普通人群中,死亡率(ASMR 和 ASMR)在女性和男性中均显著下降。在透析患者中,骨折后死亡率(SMR,主要是 180 天死亡率)仍然比普通人群高两倍,没有改善的趋势。
瑞典普通人群中女性和男性的髋部骨折发病率和随后的死亡率均有所下降。在透析患者中,女性的髋部骨折发病率下降,但男性没有下降,而骨折后死亡率没有改善,发病率和随后的死亡率仍然比普通人群高 3 至 5 倍和 2 倍。